Health & Drug News COBENFY September 26, 2024 Read More » AQNEURSA September 25, 2024 Read More » MIPLYFFA™ September 20, 2024 Read More » PAVBLU August 23, 2024 Read More » LIVDELZI August 14, 2024 Read More » CREXONT August 7, 2024 Read More » RECALLS August 5, 2024 Read More » GENERIC DRUG APPROVALS July 22, 2024 Read More » FDA Approves mRESVIA for Prevention of Lower Respiratory Tract Disease Causedby RSV May 31, 2024 Read More » Page1 Page2 Page3 Page4 Page5 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
FDA Approves mRESVIA for Prevention of Lower Respiratory Tract Disease Causedby RSV May 31, 2024 Read More »